Giulia D. Santo
Catanzaro, 88100, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 50 publications
Editorial: Advances in PET-CT imaging, vol. II.
Journal: Frontiers in medicine
Published: August 04, 2026
PSMA PET/CT-guided salvage elective nodal radiotherapy for nodal metastases after radical prostatectomy: a bi-institutional long-term outcome analysis.
Journal: European journal of nuclear medicine and molecular imaging
Published: June 08, 2026
Correction: Biochemical failure after radical prostatectomy with PSA ≤ 1 ng/mL: prediction of PSMA-positive metastatic disease.
Journal: Annals of nuclear medicine
Published: May 25, 2026
Tumour-absorbed dose and efficacy of peptide receptor radionuclide therapy with [90Y]Y-DOTATOC in patients with refractory meningioma: a single-centre experience.
Journal: European journal of nuclear medicine and molecular imaging
Published: April 30, 2026
[18F]FDG PET during immunotherapy: mind the gap between evidence, imaging guidelines, and oncology practice.
Journal: European journal of nuclear medicine and molecular imaging
Published: April 28, 2026
Reply to "Methodological and clinical considerations on predicting PSMA-positive metastatic disease in early biochemical failure after radical prostatectomy: comment on Santo et al."
Journal: Annals of nuclear medicine
Published: March 30, 2026
Real-world outcomes of [177Lu]Lu-PSMA-I&T in [18F]FDG-positive metastatic castration-resistant prostate cancer: factors related to response and survival.
Journal: European journal of nuclear medicine and molecular imaging
Published: January 29, 2026
Paving the Way for CCK2R-Targeted Peptide Receptor Radionuclide Therapy with [177Lu]Lu-DOTA-MGS5 in Patients with Small Cell Lung Cancer.
Journal: Pharmaceutics
Published: December 23, 2025
Peptide receptor radionuclide therapy in neuroendocrine tumours: advances, combination strategies, and future directions.
Journal: European journal of nuclear medicine and molecular imaging
Published: November 21, 2025
Biochemical failure after radical prostatectomy with PSA ≤ 1 ng/mL: prediction of PSMA-positive metastatic disease.
Journal: Annals of nuclear medicine
Published: November 17, 2025
Diagnostic Yield of [18F]FDG PET/CT in FUO: An Italian Multicenter Study of 929 Patients.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: October 22, 2025
Peptide receptor radionuclide therapy alone or in combination with temozolomide plus/minus capecitabine in [18F]FDG-positive metastatic neuroendocrine tumors.
Journal: European journal of nuclear medicine and molecular imaging
Published: August 11, 2025
Last Updated: 09/26/2026